Results for Diabetic Retinopathy

M. alba has protective effect on diabetic retinopathy.

Article Published Date : Apr 07, 2016
Study Type : Animal Study
Additional Links
Substances : White Mulberry : CK(140) : AC(54)
Diseases : Diabetic Retinopathy : CK(290) : AC(121)
Pharmacological Actions : Anti-Apoptotic : CK(2905) : AC(1672), Anti-Inflammatory Agents : CK(20859) : AC(8334), Hypoglycemic Agents : CK(5366) : AC(1338), Vascular Endothelial Growth Factor Inhibitors : CK(435) : AC(247)
Additional Keywords : Anti-Apoptotic, Anti-Inflammatory Agents, Diabetic Retinopathy, Hypoglycemic Agents, Vascular Endothelial Growth Factor Inhibitors, White Mulberry

These results indicate that shikonin treatment may prevent the loss of vision associated with diabetic retinopathy.

Article Published Date : Mar 20, 2017
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : Shikonin : CK(108) : AC(63)
Diseases : Diabetic Retinopathy : CK(290) : AC(121)
Pharmacological Actions : Anti-Apoptotic : CK(2905) : AC(1672), Anti-Inflammatory Agents : CK(20859) : AC(8334), Cyclooxygenase 2 Inhibitors : CK(1589) : AC(926)
Additional Keywords : Anti-Apoptotic, Anti-Inflammatory Agents, Cyclooxygenase 2 Inhibitors, Diabetic Retinopathy, Shikonin

Walnut leaf extract exert protective effects against diabetic retinopathy.

Article Published Date : Oct 31, 2017
Study Type : Animal Study
Additional Links
Substances : Walnut : CK(589) : AC(137)
Diseases : Diabetic Retinopathy : CK(290) : AC(121)
Pharmacological Actions : Anti-Apoptotic : CK(2905) : AC(1672), Anti-Inflammatory Agents : CK(20859) : AC(8334), Cyclooxygenase 2 Inhibitors : CK(1589) : AC(926)
Additional Keywords : Anti-Apoptotic, Anti-Inflammatory Agents, Cyclooxygenase 2 Inhibitors, Diabetic Retinopathy, Walnut

Zerumbone protects against hyperglycemia-induced retinal damage in experimental diabetic rats.

Article Published Date : Jul 24, 2016
Study Type : Animal Study
Additional Links
Substances : Zerumbone : CK(46) : AC(0)
Diseases : Advanced Glycation End products (AGE) : CK(440) : AC(176), Diabetic Complications : CK(3199) : AC(1009), Diabetic Retinopathy : CK(290) : AC(121)
Pharmacological Actions : Hypoglycemic Agents : CK(5366) : AC(1338), Interleukin-6 Downregulation : CK(5029) : AC(1994), NF-kappaB Inhibitor : CK(3536) : AC(2098), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(6736) : AC(2815), Vascular Endothelial Growth Factor Regulator : CK(62) : AC(29)
Additional Keywords : Advanced Glycation End products (AGE), Diabetic Complications, Diabetic Retinopathy, Zerumbone : CK(5) : AC(1)

Connect with GreenMedInfo

MeWe

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.